Log In
BCIQ
Print this Print this
 

Adrenergic receptor beta (ADRB)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Adrenergic receptor beta (ADRB)

BCIQ
Print ChartPrint this
0 0 0 0 1 0 1 0 0 0 0 0 1 4 1 2 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 1 0 0 2 0 0 0 0 0 1 0
Phases of DevelopmentPilotPhase IIPhase II/IIIPhase IIIRegistrationApprovedMarketed
Cancer

0

0

0

0

0

1

0

Cardiovascular

0

0

1

1

0

0

2

Endocrine / Metabolic

0

1

0

0

0

0

0

Hematology

0

1

0

0

0

0

0

Inflammation

1

2

0

0

0

0

1

Ophthalmic

0

0

0

0

0

1

4

Pulmonary

0

0

0

0

1

0

1




 Products Targeting Adrenergic receptor beta (ADRB)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

7

$86.6M

$60.3M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today